SCHEMBL8559812

SCHEMBL8559812

COc1ccccc1CC(=O)N(C)c1ccc(C(=O)N2Cc3ccccc3Cc3ccccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
SIGMAR1 Q99720 2/20 0.41
REV1 Q9UBZ9 1/20 0.41
AVPR2 P30518 1/20 0.41
AVPR1A P37288 1/20 0.41
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPT P10636 1/20 0.40
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBA3C P0DPH7 1/20 0.40
TUBA1B P68363 1/20 0.40
TUBA4A P68366 1/20 0.40
TUBB4B P68371 1/20 0.40
TUBB3 Q13509 1/20 0.40
TUBB2A Q13885 1/20 0.40
TUBB8 Q3ZCM7 1/20 0.40
TUBA3E Q6PEY2 1/20 0.40
TUBA1A Q71U36 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8564026 0.87 AVPR1A (0.43) MEN1KMT2AAVPR2AVPR1ARAB9A
SCHEMBL8560422 0.86 AVPR1A (0.42) MEN1KMT2ASIGMAR1AVPR2AVPR1A
SCHEMBL7331203 0.84 AVPR1A (0.55) AVPR2AVPR1A
SCHEMBL8557861 0.84 AVPR1A (0.45) MEN1KMT2AAVPR2AVPR1ARAB9A
SCHEMBL8557707 0.83 ALDH1A1 (0.47) AVPR2AVPR1ARAB9ASMN1; SMN2TUBB4A
SCHEMBL8562373 0.82 AVPR1A (0.45) MEN1KMT2AAVPR2AVPR1ARAB9A
SCHEMBL8558210 0.79 AVPR1A (0.44) MEN1KMT2AAVPR2AVPR1ARAB9A
SCHEMBL8561776 0.77 SMN1; SMN2 (0.46) MEN1KMT2AAVPR2AVPR1ARAB9A
SCHEMBL8559862 0.77 AVPR2 (0.45) AVPR2AVPR1ARAB9ASMN1; SMN2MAPT
SCHEMBL5237513 0.75 TAS2R14 (0.49) MEN1KMT2ASIGMAR1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0640592-B1 N-acylated tricyclic azaheterorings useful as vasopressin antagonists AMERICAN CYANAMID CO (US) 1998-12-30 EP disclosed